$6.19
-0.14-2.21%
Last update: Nov 6, 4:00 PM
Embecta Corp (EMBC) Stock Price, Quote, News & History
EMBCNASDAQ
Embecta announces $200 million Owen Mumford deal aimed at boosting growth and expanding drug delivery in diabetes and obesity care markets.
You can purchase shares of Embecta (NASDAQ:EMBC) through any online brokerage.
Other companies in Embecta’s space includes: Alcon Inc (NYSE:ALC), Medline Inc (NASDAQ:MDLN), Solventum Corp (NYSE:SOLV), The Cooper Companies Inc (NASDAQ:COO) and Align Technology Inc (NASDAQ:ALGN).
Embecta has a consensus price target of $6.67.
The stock price for Embecta (NASDAQ: EMBC) is $6.19 last updated November 6, 2026 at 4:00 PM EST.
There are no upcoming dividends for Embecta.
Embecta does not have any upcoming earnings scheduled.
There is no upcoming split for Embecta.
Embecta is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices,...
